169 related articles for article (PubMed ID: 30686754)
21. Osmundacetone modulates mitochondrial metabolism in non-small cell lung cancer cells by hijacking the glutamine/glutamate/α-KG metabolic axis.
Yang Y; He P; Hou Y; Liu Z; Zhang X; Li N
Phytomedicine; 2022 Jun; 100():154075. PubMed ID: 35413646
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression.
Yang B; Zhang L; Cao Y; Chen S; Cao J; Wu D; Chen J; Xiong H; Pan Z; Qiu F; Chen J; Ling X; Yan M; Huang S; Zhou S; Li T; Yang L; Huang Y; Lu J
Mol Cancer; 2017 Sep; 16(1):154. PubMed ID: 28946875
[TBL] [Abstract][Full Text] [Related]
23. Suppression of lung tumorigenesis by leucine zipper/EF hand-containing transmembrane-1.
Hwang SK; Piao L; Lim HT; Minai-Tehrani A; Yu KN; Ha YC; Chae CH; Lee KH; Beck GR; Park J; Cho MH
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824095
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.
Li X; Han G; Li X; Kan Q; Fan Z; Li Y; Ji Y; Zhao J; Zhang M; Grigalavicius M; Berge V; Goscinski MA; Nesland JM; Suo Z
Oncotarget; 2017 Jul; 8(28):46363-46380. PubMed ID: 28624784
[TBL] [Abstract][Full Text] [Related]
25. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
[TBL] [Abstract][Full Text] [Related]
26. Mutant KRAS associated malic enzyme 1 expression is a predictive marker for radiation therapy response in non-small cell lung cancer.
Chakrabarti G
Radiat Oncol; 2015 Jul; 10():145. PubMed ID: 26173780
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer.
Shi X; Ma C; Zhu Q; Yuan D; Sun M; Gu X; Wu G; Lv T; Song Y
Oncotarget; 2016 May; 7(18):25558-75. PubMed ID: 27027352
[TBL] [Abstract][Full Text] [Related]
28. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
29. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
30. High resolution respirometry analysis of polyethylenimine-mediated mitochondrial energy crisis and cellular stress: Mitochondrial proton leak and inhibition of the electron transport system.
Hall A; Larsen AK; Parhamifar L; Meyle KD; Wu LP; Moghimi SM
Biochim Biophys Acta; 2013 Oct; 1827(10):1213-25. PubMed ID: 23850549
[TBL] [Abstract][Full Text] [Related]
31. By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.
Zhang ZY; Fu SL; Xu SQ; Zhou X; Liu XS; Xu YJ; Zhao JP; Wei S
Oncotarget; 2015 Jan; 6(3):1462-77. PubMed ID: 25596743
[TBL] [Abstract][Full Text] [Related]
32. CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer.
Tang H; Zhu J; Du W; Liu S; Zeng Y; Ding Z; Zhang Y; Wang X; Liu Z; Huang J
J Exp Clin Cancer Res; 2018 Jul; 37(1):131. PubMed ID: 29970127
[TBL] [Abstract][Full Text] [Related]
33. Effect of miR‑146a‑5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation.
Huang WT; Cen WL; He RQ; Xie Y; Zhang Y; Li P; Gan TQ; Chen G; Hu XH
Mol Med Rep; 2017 Dec; 16(6):8781-8792. PubMed ID: 28990079
[TBL] [Abstract][Full Text] [Related]
34. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
[TBL] [Abstract][Full Text] [Related]
35. Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma.
Wael H; Yoshida R; Kudoh S; Hasegawa K; Niimori-Kita K; Ito T
Lung Cancer; 2014 Aug; 85(2):131-40. PubMed ID: 24888228
[TBL] [Abstract][Full Text] [Related]
36. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Liu W; Yin Y; Wang J; Shi B; Zhang L; Qian D; Li C; Zhang H; Wang S; Zhu J; Gao L; Zhang Q; Jia B; Hao L; Wang C; Zhang B
Oncotarget; 2017 Jan; 8(1):179-190. PubMed ID: 27329725
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer.
Fang Y; Wang J; Wang G; Zhou C; Wang P; Zhao S; Zhao S; Huang S; Su W; Jiang P; Chang A; Xiang R; Sun P
Oncotarget; 2017 Apr; 8(16):26702-26717. PubMed ID: 28460458
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
[TBL] [Abstract][Full Text] [Related]
39. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J
Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929
[TBL] [Abstract][Full Text] [Related]
40. Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation.
Okumura S; Sasaki T; Minami Y; Ohsaki Y
J Thorac Oncol; 2012 Jan; 7(1):49-56. PubMed ID: 22089115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]